JUM etoc signup
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Herbay, A.
Right arrow Articles by Häussinger, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Herbay, A.
Right arrow Articles by Häussinger, D.
© 2004 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 23:1557-1568 • 0278-4297

Real-time Imaging With the Sonographic Contrast Agent SonoVue

Differentiation Between Benign and Malignant Hepatic Lesions

Alexandra von Herbay, MD, Christoph Vogt, MD, Reinhard Willers, PhD and Dieter Häussinger, MD

Department of Medicine, University of Tübingen, Tübingen, Germany (A.v.H.); and Department of Medicine (A.v.H., C.V., D.H.) and Computer Center (R.W.), University of Düsseldorf, Düsseldorf, Germany.

Address correspondence and reprint requests to Alexandra von Herbay, MD, Department of Gastroenterology, Hepatology, and Infectiology, Clinic of Internal Medicine 1, University of Tübingen, Otfried-Müller-Strasse 10, D-72076 Tübingen, Germany.

Objective. We investigated the ability of contrast-enhanced sonography with SonoVue (Altana Pharma, Konstanz, Germany), a sulfur hexafluoride microbubble contrast agent, to reveal differences between benign and malignant focal hepatic lesions. Methods. One hundred twenty-six lesions in 124 patients with focal hepatic lesions detected by B-mode sonography (hepatocellular carcinoma, n = 36; metastasis, n = 25; cholangiocellular carcinoma, n = 1; lymphoma, n = 2; focal nodular hyperplasia, n = 9; adenoma, n = 4; regenerative cirrhotic nodule, n = 13; hemangioma, n = 29; and focal hyposteatosis, n = 7) were examined in a prospective study. After intravenous injection of 2.4 mL of SonoVue, the liver was examined continuously for 3 minutes by low–mechanical index pulse inversion sonography. Results. For the discrimination of malignant versus benign liver lesions, SonoVue-enhanced sonography improved sensitivity from 78% to 100% and specificity from 23% to 92% compared with baseline sonography. Receiver operating characteristic analysis revealed a significant improvement in this discrimination (area under the receiver operating characteristic curve, 0.510 ± 0.054 [SD] at baseline sonography, 0.998 ± 0.003 with SonoVue-enhanced sonography; P < .001). The following flow patterns in the early phase were diagnosis specific: early central starlike pattern for focal nodular hyperplasia, peripheral globular-nodular pattern for hemangioma, and diffuse arterial enhancement for malignant lesions. Homogeneous enhancement in the late phase was predictive for benign lesions (P < .001). Conversely, 93% of patients without contrast enhancement in the late phase had malignant lesions (P < .001). Conclusions. SonoVue-enhanced sonography has greater specificity and sensitivity than baseline sonography for the differentiation of benign and malignant liver lesions.

Key Words: contrast media • hemangioma • hepatocellular carcinoma • liver • metastasis • sonography • SonoVue

Abbreviations: Az, area under the receiver operating characteristic curve • CT, computed tomography • FNH, focal nodular hyperplasia • HCC, hepatocellular carcinoma • MI, mechanical index • MR, magnetic resonance • ROC, receiver operating characteristic




This article has been cited by other articles:


Home page
RadiologyHome page
H. Maruyama, H. Ishibashi, M. Takahashi, F. Imazeki, and O. Yokosuka
Effect of Signal Intensity from the Accumulated Microbubbles in the Liver for Differentiation of Idiopathic Portal Hypertension from Liver Cirrhosis
Radiology, August 1, 2009; 252(2): 587 - 594.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. von Herbay, A.-P. Barreiros, A. Ignee, J. Westendorff, M. Gregor, P. R. Galle, and C. Dietrich
Contrast-Enhanced Ultrasonography With SonoVue: Differentiation Between Benign and Malignant Lesions of the Spleen
J. Ultrasound Med., April 1, 2009; 28(4): 421 - 434.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
W. Luo, K. Numata, M. Kondo, M. Morimoto, K. Sugimori, K. Hirasawa, A. Nozaki, X. Zhou, and K. Tanaka
Sonazoid-Enhanced Ultrasonography for Evaluation of the Enhancement Patterns of Focal Liver Tumors in the Late Phase by Intermittent Imaging With a High Mechanical Index
J. Ultrasound Med., April 1, 2009; 28(4): 439 - 448.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
G.-J. Liu, M.-D. Lu, X.-Y. Xie, H.-X. Xu, Z.-F. Xu, Y.-L. Zheng, J.-Y. Liang, and W. Wang
Real-time Contrast-Enhanced Ultrasound Imaging of Infected Focal Liver Lesions
J. Ultrasound Med., April 1, 2008; 27(4): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-X. Xu, X.-Y. Xie, M.-D. Lu, G.-J. Liu, Z.-F. Xu, J.-Y. Liang, and L.-D. Chen
Unusual Benign Focal Liver Lesions: Findings on Real-time Contrast-Enhanced Sonography
J. Ultrasound Med., February 1, 2008; 27(2): 243 - 254.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M.-H. Chen, W. Wu, W. Yang, Y. Dai, W. Gao, S.-S. Yin, and K. Yan
The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy
J. Ultrasound Med., August 1, 2007; 26(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
K. Numata, H. Oka, M. Morimoto, K. Sugimori, R. Kunisaki, H. Nihonmatsu, K. Matsuo, Y. Nagano, A. Nozawa, and K. Tanaka
Differential Diagnosis of Gallbladder Diseases With Contrast-Enhanced Harmonic Gray Scale Ultrasonography
J. Ultrasound Med., June 1, 2007; 26(6): 763 - 774.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-X. Xu, G.-J. Liu, M.-D. Lu, X.-Y. Xie, Z.-F. Xu, Y.-L. Zheng, and J.-Y. Liang
Characterization of Small Focal Liver Lesions Using Real-time Contrast-Enhanced Sonography: Diagnostic Performance Analysis in 200 Patients.
J. Ultrasound Med., March 1, 2006; 25(3): 349 - 361.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. Gorg and T. Bert
Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions.
Am. J. Roentgenol., March 1, 2006; 186(3): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-X. Xu, M.-D. Lu, G.-J. Liu, X.-Y. Xie, Z.-F. Xu, Y.-L. Zheng, and J.-Y. Liang
Imaging of Peripheral Cholangiocarcinoma With Low-Mechanical Index Contrast-Enhanced Sonography and SonoVue: Initial Experience
J. Ultrasound Med., January 1, 2006; 25(1): 23 - 33.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
C. Gorg, T. Bert, and R. Kring
Contrast-Enhanced Sonography of the Lung for Differential Diagnosis of Atelectasis
J. Ultrasound Med., January 1, 2006; 25(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Gorg, T. Bert, and K. Gorg
Contrast-Enhanced Sonography for Differential Diagnosis of Pleurisy and Focal Pleural Lesions of Unknown Cause
Chest, December 1, 2005; 128(6): 3894 - 3899.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Institute of Ultrasound in Medicine.